| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A limited sample model to predict area under the drug concentration curve for 17-(allylamino)-17-demethoxygeldanamycin and its active metabolite 17-(amino)-17-demethoxygeldanomycin
|
Furth, Alfred F.
|
|
2007
|
61 |
1 |
p. 39-45
|
artikel
|
| 2 |
A phase II trial of modified weekly irinotecan and cisplatin for chemotherapy-naïve patients with metastatic or recurrent squamous cell carcinoma of the esophagus
|
Lee, Dae Ho
|
|
2007
|
61 |
1 |
p. 83-88
|
artikel
|
| 3 |
A phase I study of capecitabine and a modulatory dose of irinotecan in metastatic breast cancer
|
O’Connor, T.
|
|
2007
|
61 |
1 |
p. 125-131
|
artikel
|
| 4 |
Capecitabine and doxorubicin combination chemotherapy as salvage therapy in pretreated advanced gastric cancer
|
Shin, Sang Joon
|
|
2007
|
61 |
1 |
p. 157-165
|
artikel
|
| 5 |
Comparison of pharmacokinetic and metabolic profiling among gossypol, apogossypol and apogossypol hexaacetate
|
Jia, Lee
|
|
2007
|
61 |
1 |
p. 63-73
|
artikel
|
| 6 |
Docetaxel, low-dose estramustine, and doxifluridine in hormone-refractory metastatic prostate cancer
|
Wada, Yoshihiro
|
|
2007
|
61 |
1 |
p. 53-61
|
artikel
|
| 7 |
Hydroxyl radical scavenger ameliorates cisplatin-induced nephrotoxicity by preventing oxidative stress, redox state unbalance, impairment of energetic metabolism and apoptosis in rat kidney mitochondria
|
Santos, N. A. G.
|
|
2007
|
61 |
1 |
p. 145-155
|
artikel
|
| 8 |
Modification of multidrug resistance of tumor cells by ionizing radiation
|
Korystov, Yuri N.
|
|
2007
|
61 |
1 |
p. 15-21
|
artikel
|
| 9 |
Neurotoxicity of FOLFOX-4 as adjuvant treatment for patients with colon and gastric cancer: a randomized study of two different schedules of oxaliplatin
|
Petrioli, Roberto
|
|
2007
|
61 |
1 |
p. 105-111
|
artikel
|
| 10 |
Orally administered FTS (salirasib) inhibits human pancreatic tumor growth in nude mice
|
Haklai, Roni
|
|
2007
|
61 |
1 |
p. 89-96
|
artikel
|
| 11 |
Pharmacokinetics of oxaliplatin in patients with severe hepatic dysfunction
|
Baur, Martina
|
|
2007
|
61 |
1 |
p. 97-104
|
artikel
|
| 12 |
Pharmacometrics and delivery of novel nanoformulated PEG-b-poly(ε-caprolactone) micelles of rapamycin
|
Yáñez, Jaime A.
|
|
2007
|
61 |
1 |
p. 133-144
|
artikel
|
| 13 |
Phase II clinical study of gemcitabine in the treatment of patients with advanced nasopharyngeal carcinoma after the failure of platinum-based chemotherapy
|
Zhang, Li
|
|
2007
|
61 |
1 |
p. 33-38
|
artikel
|
| 14 |
Phase II trial of gemcitabine combined with cisplatin in patients with inoperable biliary tract carcinomas
|
Lee, Jeeyun
|
|
2007
|
61 |
1 |
p. 47-52
|
artikel
|
| 15 |
Prospective validation of a novel IV busulfan fixed dosing for paediatric patients to improve therapeutic AUC targeting without drug monitoring
|
Vassal, G.
|
|
2007
|
61 |
1 |
p. 113-123
|
artikel
|
| 16 |
The combination of capecitabine and irinotecan in treating 5-Fluorouracil- and Oxaliplatin-pretreated metastatic colorectal cancer
|
Shin, Sang Joon
|
|
2007
|
61 |
1 |
p. 75-81
|
artikel
|
| 17 |
The gemcitabine, docetaxel, and capecitabine (GTX) regimen for metastatic pancreatic cancer: a retrospective analysis
|
Fine, Robert L.
|
|
2007
|
61 |
1 |
p. 177
|
artikel
|
| 18 |
The gemcitabine, docetaxel, and capecitabine (GTX) regimen for metastatic pancreatic cancer: a retrospective analysis
|
Fine, Robert L.
|
|
2007
|
61 |
1 |
p. 167-175
|
artikel
|
| 19 |
The impact of delay in cryo-fixation on biomarkers of Src tyrosine kinase activity in human breast and bladder cancers
|
Jones, Rob J.
|
|
2007
|
61 |
1 |
p. 23-32
|
artikel
|
| 20 |
Third-line therapy for metastatic colorectal cancer
|
Gundgaard, M. G.
|
|
2007
|
61 |
1 |
p. 1-13
|
artikel
|
Tijdschrift beschrijving